Bronte Capital 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Bronte Capital disclosed 43 US equity positions worth $956.8m in its Q4 2025 13F filing. The largest position was REGN at 14.3% of the reported book, followed by GOOGL and IBKR. Against the Q3 2025 filing, it opened 16 new positions, added to 2 and reduced 18 among the top 43 holdings.
What did Bronte Capital own in Q4 2025? Top 43 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | REGN REGENERON PHARMACEUTICALS | Healthcare | 14.3% | $136.4m | 176,768 | -2% | reduced |
| 2 | GOOGL ALPHABET INC | Communication Services | 13.6% | $130.2m | 415,963 | -3% | reduced |
| 3 | IBKR INTERACTIVE BROKERS GROUP | Financial Services | 10.0% | $95.6m | 1,486,294 | -16% | reduced |
| 4 | VISA INC-CLASS A SHARES | 8.6% | $82.5m | 235,154 | -0% | held | |
| 5 | BRK/B BERKSHIRE HATHAWAY INC DEL | 8.5% | $81.6m | 162,327 | -7% | reduced | |
| 6 | AMZN AMAZON COM INC | Consumer Cyclical | 6.7% | $64.1m | 277,641 | -5% | reduced |
| 7 | PM PHILIP MORRIS INTL INC | Consumer Defensive | 6.7% | $63.9m | 398,556 | -5% | reduced |
| 8 | COF CAPITAL ONE FINL CORP | Financial Services | 4.4% | $42.5m | 175,540 | -34% | reduced |
| 9 | CTVA CORTEVA INC | Basic Materials | 4.0% | $38.1m | 569,033 | -0% | held |
| 10 | FCNCA FIRST CTZNS BANCSHARES INC N | Financial Services | 3.8% | $36.6m | 17,072 | -17% | reduced |
| 11 | VANECK ETF TRUST | 2.0% | $18.7m | 217,657 | -29% | reduced | |
| 12 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.6% | $15.5m | 38,864 | 11% | added |
| 13 | SOTERA HEALTH CO | 1.6% | $15.4m | 874,926 | -1% | reduced | |
| 14 | GHC GRAHAM HLDGS CO | Industrials | 1.5% | $14.7m | 13,355 | -0% | held |
| 15 | HLF HERBALIFE NUTRITION LTD | Consumer Defensive | 1.5% | $14.4m | 1,120,175 | -18% | reduced |
| 16 | PINS PINTEREST INC | Communication Services | 1.4% | $13.3m | 512,196 | -21% | reduced |
| 17 | TBBB BBB FOODS INC | Consumer Defensive | 1.4% | $13.2m | 394,158 | – | new |
| 18 | IBB ISHARES TR | 1.3% | $12.2m | 72,350 | -74% | reduced | |
| 19 | SQM SOCIEDAD QUIMICA Y MINERA DE | Basic Materials | 1.2% | $11.2m | 163,457 | -1% | reduced |
| 20 | SBH SALLY BEAUTY HLDGS INC | Consumer Cyclical | 1.1% | $10.5m | 737,250 | -32% | reduced |
| 21 | NEM NEWMONT CORP | Basic Materials | 0.8% | $7.8m | 77,856 | -0% | held |
| 22 | B BARRICK MNG CORP | Basic Materials | 0.8% | $7.2m | 164,856 | -23% | reduced |
| 23 | RAMP LIVERAMP HLDGS INC | Technology | 0.7% | $6.8m | 231,994 | 0% | held |
| 24 | BBWI BATH & BODY WORKS INC | Consumer Cyclical | 0.5% | $5.1m | 254,611 | 122% | added |
| 25 | MDLZ MONDELEZ INTL INC | Consumer Defensive | 0.4% | $3.5m | 64,547 | -2% | reduced |
| 26 | VANECK ETF TRUST | 0.3% | $3.2m | 27,763 | -82% | reduced | |
| 27 | FICO FAIR ISAAC CORP | Technology | 0.3% | $2.6m | 1,567 | – | new |
| 28 | TPB TURNING PT BRANDS INC | Consumer Defensive | 0.3% | $2.6m | 24,372 | – | new |
| 29 | RSKD RISKIFIED LTD | Technology | 0.3% | $2.6m | 513,676 | -0% | held |
| 30 | NICE NICE LTD | Technology | 0.2% | $2.3m | 20,322 | – | new |
| 31 | OLED UNIVERSAL DISPLAY CORP | Technology | 0.1% | $1.4m | 11,653 | – | new |
| 32 | JAMES RIV GROUP HOLDINGS INC | 0.1% | $785.9k | 123,575 | – | new | |
| 33 | ENVX ENOVIX CORPORATION | Industrials | 0.0% | $84.4k | 11,550 | 0% | held |
| 34 | GUTS FRACTYL HEALTH INC | 0.0% | $37.2k | 16,905 | – | new | |
| 35 | ALEC ALECTOR INC | Healthcare | 0.0% | $30.1k | 19,282 | – | new |
| 36 | CHRS COHERUS ONCOLOGY INC | Healthcare | 0.0% | $27.4k | 19,282 | – | new |
| 37 | IVVD INVIVYD INC | Healthcare | 0.0% | $27.2k | 11,012 | – | new |
| 38 | CRBU CARIBOU BIOSCIENCES INC | Healthcare | 0.0% | $24.8k | 15,627 | – | new |
| 39 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 0.0% | $22.7k | 18,613 | – | new |
| 40 | FATE FATE THERAPEUTICS INC | Healthcare | 0.0% | $22.5k | 22,853 | – | new |
| 41 | MILESTONE PHARMACEUTICALS IN | 0.0% | $21.0k | 10,414 | – | new | |
| 42 | RANI RANI THERAPEUTICS HLDGS INC | 0.0% | $20.1k | 14,868 | – | new | |
| 43 | CCCC C4 THERAPEUTICS INC | Healthcare | 0.0% | $19.2k | 10,033 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.